Literature DB >> 33225390

"Modern Endovascular Therapy".

Matthew Blecha1, Vivian Gahtan2,3.   

Abstract

INTRODUCTION: The past 25 years have been witness to a revolution in how vascular care is delivered. The majority of arterial and venous interventions have converted from open surgery to minimally invasive percutaneous endovascular procedures.
METHODS: This surgical innovations symposium article reviews current endovascular therapy in multiple vascular beds with a primary focus on carotid artery occlusive disease, aortic pathologies, and lower extremity arterial occlusive disease. Mesenteric arterial occlusive disease and lower extremity venous endovascular therapies are also briefly discussed. Indications for intervention, treatment examples and outcomes analysis are presented. While not reviewed in this article, endovascular therapy has also become first line in the treatment of coronary artery disease, chronic mesenteric arterial occlusive disease, superficial venous reflux, central vein occlusion, and acute venous thrombus intervention when indicated.
CONCLUSION: Endovascular therapies are used in all vascular beds to treat the full spectrum of vascular pathologies. Aneurysm disease, atherosclerotic arterial occlusive disease, acute arterial and venous thrombosis, ongoing hemorrhage, and venous reflux are among the issues which can be addressed by endovascular means. The minimally invasive nature of endovascular treatments in what is largely a very co-morbid patient cohort is an attractive method of avoiding major procedural related morbidity and mortality.
© 2020. Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2020        PMID: 33225390     DOI: 10.1007/s00268-020-05875-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  49 in total

1.  Percutaneous versus femoral cutdown access for endovascular aneurysm repair.

Authors:  Dominique B Buck; Eleonora G Karthaus; Peter A Soden; Klaas H J Ultee; Joost A van Herwaarden; Frans L Moll; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2015-03-28       Impact factor: 4.268

2.  Association of Transcarotid Artery Revascularization vs Transfemoral Carotid Artery Stenting With Stroke or Death Among Patients With Carotid Artery Stenosis.

Authors:  Marc L Schermerhorn; Patric Liang; Jens Eldrup-Jorgensen; Jack L Cronenwett; Brian W Nolan; Vikram S Kashyap; Grace J Wang; Raghu L Motaganahalli; Mahmoud B Malas
Journal:  JAMA       Date:  2019-12-17       Impact factor: 56.272

3.  Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.

Authors:  Virginia J Howard; James F Meschia; Brajesh K Lal; Tanya N Turan; Gary S Roubin; Robert D Brown; Jenifer H Voeks; Kevin M Barrett; Bart M Demaerschalk; John Huston; Ronald M Lazar; Wesley S Moore; Virginia G Wadley; Seemant Chaturvedi; Claudia S Moy; Marc Chimowitz; George Howard; Thomas G Brott
Journal:  Int J Stroke       Date:  2017-05-02       Impact factor: 5.266

4.  Transcaval embolization as an alternative technique for the treatment of type II endoleak after endovascular aortic aneurysm repair.

Authors:  Salvatore T Scali; Adrian Vlada; Catherine K Chang; Adam W Beck
Journal:  J Vasc Surg       Date:  2013-01-09       Impact factor: 4.268

5.  Type 2 endoleak embolization comparison: translumbar embolization versus modified transarterial embolization.

Authors:  S William Stavropoulos; Jin Park; Ronald Fairman; Jeffrey Carpenter
Journal:  J Vasc Interv Radiol       Date:  2009-08-19       Impact factor: 3.464

6.  Protected carotid-artery stenting versus endarterectomy in high-risk patients.

Authors:  Jay S Yadav; Mark H Wholey; Richard E Kuntz; Pierre Fayad; Barry T Katzen; Gregory J Mishkel; Tanvir K Bajwa; Patrick Whitlow; Neil E Strickman; Michael R Jaff; Jeffrey J Popma; David B Snead; Donald E Cutlip; Brian G Firth; Kenneth Ouriel
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

7.  Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion.

Authors:  Peter L Faries; Hadley Cadot; Gautam Agarwal; K Craig Kent; Larry H Hollier; Michael L Marin
Journal:  J Vasc Surg       Date:  2003-06       Impact factor: 4.268

8.  Transfemoral intraluminal graft implantation for abdominal aortic aneurysms.

Authors:  J C Parodi; J C Palmaz; H D Barone
Journal:  Ann Vasc Surg       Date:  1991-11       Impact factor: 1.466

9.  Five-year reintervention after endovascular abdominal aortic aneurysm repair in the Vascular Quality Initiative.

Authors:  Jesse A Columbo; Niveditta Ramkumar; Pablo Martinez-Camblor; Ravinder Kang; Bjoern D Suckow; A James O'Malley; Art Sedrakyan; Philip P Goodney
Journal:  J Vasc Surg       Date:  2019-08-27       Impact factor: 4.268

10.  Risk factors associated with microembolization after carotid intervention.

Authors:  Joseph Sabat; Diane Bock; Chiu-Hsieh Hsu; Tze-Woei Tan; Craig Weinkauf; Theodore Trouard; Gloria Guzman Perez-Carrillo; Wei Zhou
Journal:  J Vasc Surg       Date:  2019-09-05       Impact factor: 4.860

View more
  1 in total

1.  Pushing the Surgical Envelope.

Authors:  Rifat Latifi
Journal:  World J Surg       Date:  2021-05-20       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.